NCT03432975

Brief Summary

The study will be conducted at the Department of Periodontology, Cliniques universitaires Saint Luc. Patients diagnosed with Generalized Chronic Periodontitis (GChP) based on the current classification of the American Academy of Periodontology will be included. Detailed medical, periodontal and dental history will be obtained. Those who will fulfill the inclusion/exclusion criteria will be invited to participate in the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 18, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 14, 2018

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2019

Completed
Last Updated

July 15, 2019

Status Verified

July 1, 2019

Enrollment Period

1.7 years

First QC Date

February 8, 2018

Last Update Submit

July 12, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of subjects reaching ≤ 4 mm in periodontal sites with PPD ≥ 5 mm

    The primary objective of this study is to determine the effect of PVI on periodontal probing depth (PPD).

    up to 6 months

Study Arms (2)

Povidone Iodine 10%

EXPERIMENTAL

The side of the mouth receiving the subgingival irrigations of povidone iodine.

Drug: Povidone-Iodine 10%

Sterile saline solution

PLACEBO COMPARATOR

The other side of the mouth will be irrigated with a sterile saline solution.

Drug: Saline Solution

Interventions

The side of the mouth receiving the subgingival irrigations of povidone iodine 10% (test group)

Povidone Iodine 10%

The other side of the mouth will be irrigated with a sterile saline solution (control group)

Sterile saline solution

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 30 years of age
  • At least 15 teeth (excluding third molars and teeth with advanced decay indicated for extraction)
  • Any history of periodontal treatment in the previous 6 months
  • No removable prosthesis
  • A minimum of 6 teeth with at least one site each with periodontal probing depth (PPD) and clinical attachment level (CAL) ≥5 mm
  • At least 30% of the sites with PPD and CAL ≥4 mm and bleeding on probing (BOP)

You may not qualify if:

  • Any sensitivity or allergy to any of the products that will be used in the study
  • Thyroid dysfunction
  • Systemic disease (ASA II or more)
  • Need for antibiotic pre-medication for routine dental therapy
  • Antibiotic therapy in the previous 3 months
  • Pregnancy and breastfeeding
  • Current smokers (more than 5 cigarettes a day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques Universitaires Saint-Luc

Brussels, 1200, Belgium

RECRUITING

MeSH Terms

Conditions

Chronic Periodontitis

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Central Study Contacts

Selena Toma, Parodontologist

CONTACT

Selma Kessler, Dentist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 20 patients (=40 half-mouth); 20 half-mouth per group
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2018

First Posted

February 14, 2018

Study Start

December 18, 2017

Primary Completion

August 31, 2019

Study Completion

August 31, 2019

Last Updated

July 15, 2019

Record last verified: 2019-07

Locations